Education and Mentoring for HIV Prevention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate how effectively pharmacists in Louisiana can provide PrEP (Pre-Exposure Prophylaxis, a medication for HIV prevention). It focuses on training pharmacists to understand and address health disparities and biases that might affect access to PrEP. The study also examines how state pharmacy policies impact equitable access to these medications. It specifically targets pharmacists in Louisiana who are already prescribing PrEP. As an unphased trial, this study offers participants the opportunity to contribute to improving healthcare access and equity in their community.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this education and mentoring method is safe for pharmacists?
A previous study showed that education and mentoring programs for healthcare providers are safe and well-tolerated. Participants in similar programs reported no major side effects. This suggests that the education and mentoring approach being tested is likely safe for pharmacists in the trial. The focus is on enhancing their knowledge and skills, not on administering or taking medication, so physical safety concerns are minimal.
Why are researchers excited about this trial?
Researchers are excited about this trial because it's exploring a new way to make HIV prevention more accessible by involving community-based pharmacies in Louisiana. Unlike traditional methods where PrEP prescriptions might only be available through clinics or hospitals, this program trains local pharmacists to prescribe and monitor PrEP. This could significantly increase access to HIV prevention, especially in areas with fewer healthcare facilities, making it easier for people to get the protection they need.
What evidence suggests that this education and mentoring program is effective for increasing equitable PrEP prescribing?
Research shows that training pharmacists in PrEP (Pre-Exposure Prophylaxis) education can greatly enhance their ability to prescribe and manage this HIV prevention treatment. In this trial, community-based pharmacies throughout Louisiana will join a cohort of trained pharmacies for PrEP prescriptions. Studies have found that pharmacists who receive special training during their residency are more effective at increasing the delivery and use of PrEP. This training equips pharmacists with the knowledge and confidence to assess patients for PrEP and initiate prescriptions. Additionally, guidance and educational materials on best practices for prescribing PrEP further support pharmacists in their role. This approach aims to improve equitable access to PrEP, especially in resource-limited communities.12345
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Training
Pharmacists undergo training to improve competence and capacity in PrEP prescribing, focusing on health disparities and implicit bias
Implementation
Implementation of a community-pharmacy based intervention to address PrEP prescribing among target populations
Follow-up
Participants are monitored for the impact of training and implementation on PrEP prescribing patterns
What Are the Treatments Tested in This Trial?
Interventions
- Education and Mentoring for Prescribing Pharmacists
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Community based pharmacies throughout Louisiana will be enrolled in a cohort of trained pharmacies for PrEP prescriptions for patients seeking HIV prevention medication.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Xavier University of Louisiana.
Lead Sponsor
Louisiana Public Health Institute
Collaborator
Citations
Integrating HIV Pre-Exposure Prophylaxis (PrEP) Education ...
Our study revealed PrEP training during residency was effective per stated objectives and may be an important tool to increase PrEP delivery/uptake.
2.
journals.plos.org
journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0328713&type=printableDevelopment and evaluation of an online HIV pre- exposure ...
This training was intended to equip pharmacists with the necessary knowledge and confidence to conduct PrEP assessments and initiate.
Study Details | NCT06530225 | Are Louisiana Pharmacists ...
In addition, the pharmacists will receive mentorship and receive an implementation toolkit on best practices for PrEP prescribing.
Assessing pharmacy students' HIV pre-exposure ...
We conducted a cross-sectional web-based survey of student pharmacists in their final two years of education and training at the three University of California ...
HIV PrEP: An Opportunity for Pharmacists
When taken daily, PrEP is highly effective for preventing HIV from sex or injection drug use. It is even more effective when combined with ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.